MRVI — Maravai LifeSciences Holdings, Inc.
6 mentions in the last 24 hours · 0.03% of all mentions
Why people talked about MRVI (2026-11-05)
- Maravai LifeSciences reported Q3 2026 financial results, including an adjusted EPS of -$0.03.
- The reported revenue was $45.9 million, beating the $43.4 million estimate.
- The company issued a press release and Form 8-K filing regarding these Q3 earnings.
| Bluesky | 2 | community |
| GDELT | 1 | news |
| Marketaux | 1 | news |
| RSS Bundle | 1 | news |
| SEC EDGAR 8-K | 1 | filings |